Back to Search

DR. CHINAR AGARWAL M.D.

M.D.

Hospitalist Physician

NPI: 1265872691IndividualAccepts Medicare

Specialties, Licenses & Credentials

Critical Care Medicine (Internal Medicine) Physician

Internal Medicine — Critical Care Medicine

Code: 207RC0200X

MD182044(OR)
Hospitalist PhysicianPrimary

Hospitalist

Code: 208M00000X

MD182044(OR)

Education

OTHER

Class of 2012

Research & Publications (20)

Fractionation of high molecular weight tannins in grape seed extract and identification of procyanidin B2-3,3'-di-O-gallate as a major active constituent causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cells.
PMID 17331955·Carcinogenesis·2007
8-other
Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells.
PMID 17341659·Carcinogenesis·2007
8-other
Healing and normal fibroblasts exhibit differential proliferation, collagen production, alpha-SMA expression, and contraction.
PMID 16568347·Ann Biomed Eng·2006
7-preclinical
Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells.
PMID 17172433·Mol Cancer Ther·2006
8-other
Pseudohypoparathyroidism: a rare cause of bilateral slipped capital femoral epiphysis.
PMID 16939757·J Pediatr·2006
5-case
Anti-angiogenic efficacy of grape seed extract in endothelial cells.
PMID 14767522·Oncol Rep·2004
8-other
Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
PMID 14614451·Oncogene·2003
8-other
Grape seed extract induces apoptotic death of human prostate carcinoma DU145 cells via caspases activation accompanied by dissipation of mitochondrial membrane potential and cytochrome c release.
PMID 12419835·Carcinogenesis·2002
8-other
A polyphenolic fraction from grape seeds causes irreversible growth inhibition of breast carcinoma MDA-MB468 cells by inhibiting mitogen-activated protein kinases activation and inducing G1 arrest and differentiation.
PMID 10914742·Clin Cancer Res·2000
7-preclinical
Anticarcinogenic effect of a polyphenolic fraction isolated from grape seeds in human prostate carcinoma DU145 cells: modulation of mitogenic signaling and cell-cycle regulators and induction of G1 arrest and apoptosis.
PMID 10942529·Mol Carcinog·2000
8-other
Inositol hexaphosphate downregulates both constitutive and ligand-induced mitogenic and cell survival signaling, and causes caspase-mediated apoptotic death of human prostate carcinoma PC-3 cells.
PMID 19544333·Mol Carcinog·2010
8-other
Gallic acid, an active constituent of grape seed extract, exhibits anti-proliferative, pro-apoptotic and anti-tumorigenic effects against prostate carcinoma xenograft growth in nude mice.
PMID 19543955·Pharm Res·2009
7-preclinical
Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products.
PMID 19640973·J Nutr·2009
6-review
p21/Cip1 and p27/Kip1 Are essential molecular targets of inositol hexaphosphate for its antitumor efficacy against prostate cancer.
PMID 19176374·Cancer Res·2009
7-preclinical
Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft.
PMID 19638451·Mol Cancer Ther·2009
7-preclinical
Safely navigating around the facial nerve in three dimensions.
PMID 18922299·Clin Plast Surg·2008
8-other
Downregulation of both p21/Cip1 and p27/Kip1 produces a more aggressive prostate cancer phenotype.
PMID 18583941·Cell Cycle·2008
7-preclinical
Silibinin impairs constitutively active TGFalpha-EGFR autocrine loop in advanced human prostate carcinoma cells.
PMID 18253818·Pharm Res·2008
8-other
Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis.
PMID 18249172·Cell Metab·2008
7-preclinical
Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice.
PMID 18445658·Mol Cancer Ther·2008
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via NYU LANGONE HOSPITALS · 5 locations total

Address
150 55TH ST
BROOKLYN, NY 11220
Practice locations map

Locations (5)

NYU LANGONE HOSPITALS

150 55TH ST, BROOKLYN, NY
(718) 630-7000

Practice Location

3181 SW SAM JACKSON PARK RD, PORTLAND, OR
(503) 494-7641

SALEM HEALTH

890 OAK ST SE, SALEM, OR
(503) 561-5200

Practice Location

3311 RIVERBEND DR., SPRINGFIELD, OR
(541) 222-5144

Practice Location

3377 RIVERBEND DR, SPRINGFIELD, OR
(541) 222-8400

Quick Facts

NPI
1265872691
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
5
Years in Practice
14
Publications
20

Are you this provider?

Claim Your Profile